EU Medical Device Firms Face Digital Deadlines
Medical device manufacturers exporting to the European Union face a series of mandatory deadlines in 2026 for compliance with the EUDAMED database. Recent briefings explain the phased rollout of the digital-first compliance platform, a central pillar of the EU's Medical Device Regulation. The updates signal a year of heightened regulatory scrutiny for the sector, requiring robust data quality and submission processes.
- The mandatory use of the first four of six EUDAMED modules begins on May 28, 2026. This follows a November 27, 2025, announcement from the European Commission that the modules for Actor Registration, UDI/Device Registration, Notified Bodies & Certificates, and Market Surveillance were fully functional. - The final two modules, covering Vigilance/Post-Market Surveillance and Clinical Investigations/Performance Studies, are still in development and will become mandatory after separate functionality notices are published. - All economic operators—including manufacturers, importers, and authorized representatives—must register in the Actor module to receive a Single Registration Number (SRN) before they can place devices on the EU market. - The Unique Device Identification (UDI) and Device Registration module is considered the most resource-intensive, requiring manufacturers to enter detailed data for every device sold in the EU. New devices must be registered before being placed on the market starting May 28, 2026, while devices already on the market have a deadline of November 27, 2026. - Failure to comply with EUDAMED registration can lead to significant penalties, including audit non-conformities, loss of access to the EU market, withdrawal of devices, and financial sanctions. - The database is a central element of the EU's Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), designed to increase transparency, enhance traceability, and strengthen market surveillance and patient safety. - A new requirement under Regulation (EU) 2024/1860 mandates that manufacturers must notify authorities at least six months in advance of any planned supply interruption for critical devices that could result in serious harm. - Industry experts warn that the complexity of data requirements, interdependencies between modules, and the potential for bottlenecks as deadlines approach are major challenges for manufacturers. Early preparation is recommended to avoid last-minute compliance risks.
